The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bishop, G. A.
Right arrow Articles by Tomai, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bishop, G. A.
Right arrow Articles by Tomai, M. A.
The Journal of Immunology, 2000, 165: 5552-5557.
Copyright © 2000 by The American Association of Immunologists

Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-8481

Gail A. Bishop2,*,{dagger},{ddagger},§, Yina Hsing{ddagger}, Bruce S. Hostager*, Sangita V. Jalukar*, Luis M. Ramirez§ and Mark A. Tomai

Departments of * Microbiology and {dagger} Internal Medicine, {ddagger} Graduate Program in Immunology, and § Veterans Administration Medical Center, Iowa City, IA 52242; and Department of Pharmacology, 3M Pharmaceuticals, St. Paul, MN 55144

The imidazoquinoline R-848, originally identified as a highly effective antiviral agent, has recently been shown to be capable of potent B lymphocyte activation. The B cell-activating properties of R-848 are strikingly similar to the effects of the CD40 ligand CD154. The present study demonstrates that this similarity extends to the intracellular signaling pathways triggered by the compound, although both overlapping and distinct mechanisms of signaling were seen. Like CD40 ligation, R-848 stimulated activation of the stress-activated protein kinases c-Jun kinase and p38 and activated the NF-{kappa}B family of transcription factors. Both R-848- and CD40-mediated B cell differentiation were dependent upon NF-{kappa}B activation, although the relative importance of individual NF-{kappa}B family members appeared to differ between R-848- and CD40-mediated signals. Both signals were partially dependent upon induction of TNF-{alpha} and IL-6, and the cytoplasmic adaptor molecule TNF receptor-associated factor 2 is involved in both R-848- and CD40-mediated differentiation.




This article has been cited by other articles:


Home page
 BloodHome page
A. L. Peters, R. M. Plenge, R. R. Graham, D. M. Altshuler, K. L. Moser, P. M. Gaffney, and G. A. Bishop
A novel polymorphism of the human CD40 receptor with enhanced function
Blood, September 1, 2008; 112(5): 1863 - 1871.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
E. L. J. M. Smits, P. Ponsaerts, Z. N. Berneman, and V. F. I. Van Tendeloo
The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
Oncologist, August 1, 2008; 13(8): 859 - 875.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. J. Martin, J. M. Lee, D. Walls, and S. D. Hayward
Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus
J. Virol., September 15, 2007; 81(18): 9748 - 9758.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Xie, B. S. Hostager, M. E. Munroe, C. R. Moore, and G. A. Bishop
Cooperation between TNF Receptor-Associated Factors 1 and 2 in CD40 Signaling
J. Immunol., May 1, 2006; 176(9): 5388 - 5400.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Borsutzky, K. Kretschmer, P. D. Becker, P. F. Muhlradt, C. J. Kirschning, S. Weiss, and C. A. Guzman
The Mucosal Adjuvant Macrophage-Activating Lipopeptide-2 Directly Stimulates B Lymphocytes via the TLR2 without the Need of Accessory Cells
J. Immunol., May 15, 2005; 174(10): 6308 - 6313.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. B. Bekeredjian-Ding, M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, and G. Hartmann
Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN
J. Immunol., April 1, 2005; 174(7): 4043 - 4050.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. L. Ahonen, C. L. Doxsee, S. M. McGurran, T. R. Riter, W. F. Wade, R. J. Barth, J. P. Vasilakos, R. J. Noelle, and R. M. Kedl
Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN
J. Exp. Med., March 15, 2004; 199(6): 775 - 784.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. L. Doxsee, T. R. Riter, M. J. Reiter, S. J. Gibson, J. P. Vasilakos, and R. M. Kedl
The Immune Response Modifier and Toll-Like Receptor 7 Agonist S-27609 Selectively Induces IL-12 and TNF-{alpha} Production in CD11c+CD11b+CD8- Dendritic Cells
J. Immunol., August 1, 2003; 171(3): 1156 - 1163.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
D. M. Koelle and L. Corey
Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research
Clin. Microbiol. Rev., January 1, 2003; 16(1): 96 - 113.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Iwata, T. Wada, K. Furuichi, N. Sakai, K. Matsushima, H. Yokoyama, and K.-i. Kobayashi
p38 Mitogen-Activated Protein Kinase Contributes to Autoimmune Renal Injury in MRL-Faslpr Mice
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 57 - 67.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. S. Hostager and G. A. Bishop
Role of TNF Receptor-Associated Factor 2 in the Activation of IgM Secretion by CD40 and CD120b
J. Immunol., April 1, 2002; 168(7): 3318 - 3322.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.